PharmaJet, a commercial-stage world leader in needle-free injection systems to improve the performance and outcomes of injectables with its enabling needle-free injection technology, announced that it ...
The 0.3mg PFS marks the first approved syringe with an anti-vascular endothelial growth factor (VEGF) to treat all forms of diabetic retinopathy with or without diabetic macular edema (DME). Genentech ...
The US Food and Drug Administration (FDA) has approved ranibizumab injection (Lucentis, Genentech) in a prefilled syringe, the company has announced. Like the Lucentis 0.5 mg vial, the 0.5 mg ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback